doi: 10.3389/fimmu.2025.1581385 Received 22 February 2025 Accepted 31 March 2025 Published 16 April 2025 Volume 16 - 2025 Edited by Eva Reali, University of Ferrara, Italy Reviewed by Anna Lisa Giuliani, University of Ferrara, Italy Nesimi Uludag, Namik Kemal University, Trkiye Updates Copyright 2025 Zhang, Pan, Sawa, Akaike and Matsunaga
Conclusion The absence of weight loss with GLP-1 therapy is not a contradiction but a reflection of its broader metabolic effects
This is the definition of the best taste: the one you barely notice
Were excited about the collaborations and breakthroughs this venture will enable
Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017
By utilizing compounded medications, we can provide access to these life-changing treatments for a fraction of the brand-name cost